FLUDARABINE PHOSPHATE, TOCILIZUMAB, CYCLOPHOSPHAMIDE, BENDAMUSTINE, PHE885
CPHE885B12201
Phase 2 small_molecule active
Quick answer
FLUDARABINE PHOSPHATE, TOCILIZUMAB, CYCLOPHOSPHAMIDE, BENDAMUSTINE, PHE885 for Adult patients with relapsed and refractory multiple myeloma is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Adult patients with relapsed and refractory multiple myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active